Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Shuler MS"" wg kryterium: Autor


Tytuł :
Retrospective analysis of trends in surgery volumes between 2016 and 2019 and impact of the insurance deductible: Cross-sectional study.
Autorzy :
Shukla D; Medical College of Georgia, Augusta, GA, USA.
Patel S; Emory University, Atlanta, GA, USA.
Clack L; University of Georgia, Athens, GA, USA.
Smith TB; Athens Orthopedic Clinic, Athens, GA, USA.
Shuler MS; Athens Orthopedic Clinic, 1765 Old West Broad St Bldg. 2 Athens, GA, 30606, USA.
Pokaż więcej
Źródło :
Annals of medicine and surgery (2012) [Ann Med Surg (Lond)] 2021 Feb 23; Vol. 63, pp. 102176. Date of Electronic Publication: 2021 Feb 23 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Continual near-infrared spectroscopy monitoring in the injured lower limb and acute compartment syndrome: an FDA-IDE trial.
Autorzy :
Shuler MS; Athens Orthopedic Clinic, Athens, Georgia, USA.
Roskosky M; Johns Hopkins University, Baltimore, Maryland, USA and The Geneva Foundation, Tacoma, Washington, USA.
Kinsey T; Athens Orthopedic Clinic, Athens, Georgia, USA.
Glaser D; Glaser Consulting, San Diego, California, USA.
Reisman W; Grady Memorial Hospital; Emory University School of Medicine, Athens, Georgia, USA.
Ogburn C; Athens Orthopedic Clinic, Athens, Georgia, USA.
Yeoman C; The Geneva Foundation, Tacoma, Washington, USA.
Wanderman NR; Mayo Clinic, Rochester, Minnesota, USA.
Freedman B; Mayo Clinic, Rochester, Minnesota, USA.
Pokaż więcej
Źródło :
The bone & joint journal [Bone Joint J] 2018 Jun 01; Vol. 100-B (6), pp. 787-797.
Typ publikacji :
Journal Article; Multicenter Study; Observational Study
MeSH Terms :
Compartment Syndromes/*diagnostic imaging
Leg Injuries/*diagnostic imaging
Muscle, Skeletal/*physiopathology
Spectroscopy, Near-Infrared/*methods
Adolescent ; Adult ; Aged ; Feasibility Studies ; Female ; Humans ; Lower Extremity ; Male ; Middle Aged ; Monitoring, Physiologic/methods ; Prospective Studies ; United States ; Young Adult
Czasopismo naukowe
Tytuł :
Efficacy and Safety of Ixekizumab in Patients with Active Psoriatic Arthritis: 52-week Results from a Phase III Study (SPIRIT-P1).
Autorzy :
van der Heijde D; From the Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands; Division of Rheumatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Immuno-Rheumatology Center, St. Luke's International Hospital, St. Luke's International University, Tokyo, Japan; Eli Lilly and Company, Indianapolis, Indiana, USA; Laboratoires Lilly France, Neuilly, France; Department of Rheumatology, Swedish Medical Center; University of Washington, Seattle, Washington, USA. .; D. van der Heijde has received consulting fees from AbbVie and Eli Lilly and Company. D.D. Gladman has received grants or consulting fees from AbbVie and Eli Lilly and Company. M. Kishimoto received honoraria and advisory fees from AbbVie and Eli Lilly and Company. S. Rathmann, S. Moriarty, C. Shuler, and H. Carlier are employees and stockholders of Eli Lilly and Company. O. Benichou is an employee and stockholder of Laboratoires Lilly France. P.J. Mease has received research grants and has been a consultant and/or speaker for AbbVie and Eli Lilly and Company. .; D. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; D.D. Gladman, MD, FRCPC, Division of Rheumatology, Department of Medicine, University of Toronto; M. Kishimoto, MD, PhD, Immuno-Rheumatology Center, St. Luke's International Hospital, St. Luke's International University; M. Okada, MD, Immuno-Rheumatology Center, St. Luke's International Hospital, St. Luke's International University; S.S. Rathmann, PhD, Eli Lilly and Company; S.R. Moriarty, MD, Eli Lilly and Company; C.L. Shuler, MS, Eli Lilly and Company; H. Carlier, PhD, Eli Lilly and Company; O. Benichou, MD, PhD, MBA, Laboratoires Lilly France; P.J. Mease, MD, Department of Rheumatology, Swedish Medical Center, and University of Washington. .
Gladman DD; From the Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands; Division of Rheumatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Immuno-Rheumatology Center, St. Luke's International Hospital, St. Luke's International University, Tokyo, Japan; Eli Lilly and Company, Indianapolis, Indiana, USA; Laboratoires Lilly France, Neuilly, France; Department of Rheumatology, Swedish Medical Center; University of Washington, Seattle, Washington, USA.; D. van der Heijde has received consulting fees from AbbVie and Eli Lilly and Company. D.D. Gladman has received grants or consulting fees from AbbVie and Eli Lilly and Company. M. Kishimoto received honoraria and advisory fees from AbbVie and Eli Lilly and Company. S. Rathmann, S. Moriarty, C. Shuler, and H. Carlier are employees and stockholders of Eli Lilly and Company. O. Benichou is an employee and stockholder of Laboratoires Lilly France. P.J. Mease has received research grants and has been a consultant and/or speaker for AbbVie and Eli Lilly and Company.; D. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; D.D. Gladman, MD, FRCPC, Division of Rheumatology, Department of Medicine, University of Toronto; M. Kishimoto, MD, PhD, Immuno-Rheumatology Center, St. Luke's International Hospital, St. Luke's International University; M. Okada, MD, Immuno-Rheumatology Center, St. Luke's International Hospital, St. Luke's International University; S.S. Rathmann, PhD, Eli Lilly and Company; S.R. Moriarty, MD, Eli Lilly and Company; C.L. Shuler, MS, Eli Lilly and Company; H. Carlier, PhD, Eli Lilly and Company; O. Benichou, MD, PhD, MBA, Laboratoires Lilly France; P.J. Mease, MD, Department of Rheumatology, Swedish Medical Center, and University of Washington.
Kishimoto M; From the Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands; Division of Rheumatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Immuno-Rheumatology Center, St. Luke's International Hospital, St. Luke's International University, Tokyo, Japan; Eli Lilly and Company, Indianapolis, Indiana, USA; Laboratoires Lilly France, Neuilly, France; Department of Rheumatology, Swedish Medical Center; University of Washington, Seattle, Washington, USA.; D. van der Heijde has received consulting fees from AbbVie and Eli Lilly and Company. D.D. Gladman has received grants or consulting fees from AbbVie and Eli Lilly and Company. M. Kishimoto received honoraria and advisory fees from AbbVie and Eli Lilly and Company. S. Rathmann, S. Moriarty, C. Shuler, and H. Carlier are employees and stockholders of Eli Lilly and Company. O. Benichou is an employee and stockholder of Laboratoires Lilly France. P.J. Mease has received research grants and has been a consultant and/or speaker for AbbVie and Eli Lilly and Company.; D. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; D.D. Gladman, MD, FRCPC, Division of Rheumatology, Department of Medicine, University of Toronto; M. Kishimoto, MD, PhD, Immuno-Rheumatology Center, St. Luke's International Hospital, St. Luke's International University; M. Okada, MD, Immuno-Rheumatology Center, St. Luke's International Hospital, St. Luke's International University; S.S. Rathmann, PhD, Eli Lilly and Company; S.R. Moriarty, MD, Eli Lilly and Company; C.L. Shuler, MS, Eli Lilly and Company; H. Carlier, PhD, Eli Lilly and Company; O. Benichou, MD, PhD, MBA, Laboratoires Lilly France; P.J. Mease, MD, Department of Rheumatology, Swedish Medical Center, and University of Washington.
Okada M; From the Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands; Division of Rheumatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Immuno-Rheumatology Center, St. Luke's International Hospital, St. Luke's International University, Tokyo, Japan; Eli Lilly and Company, Indianapolis, Indiana, USA; Laboratoires Lilly France, Neuilly, France; Department of Rheumatology, Swedish Medical Center; University of Washington, Seattle, Washington, USA.; D. van der Heijde has received consulting fees from AbbVie and Eli Lilly and Company. D.D. Gladman has received grants or consulting fees from AbbVie and Eli Lilly and Company. M. Kishimoto received honoraria and advisory fees from AbbVie and Eli Lilly and Company. S. Rathmann, S. Moriarty, C. Shuler, and H. Carlier are employees and stockholders of Eli Lilly and Company. O. Benichou is an employee and stockholder of Laboratoires Lilly France. P.J. Mease has received research grants and has been a consultant and/or speaker for AbbVie and Eli Lilly and Company.; D. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; D.D. Gladman, MD, FRCPC, Division of Rheumatology, Department of Medicine, University of Toronto; M. Kishimoto, MD, PhD, Immuno-Rheumatology Center, St. Luke's International Hospital, St. Luke's International University; M. Okada, MD, Immuno-Rheumatology Center, St. Luke's International Hospital, St. Luke's International University; S.S. Rathmann, PhD, Eli Lilly and Company; S.R. Moriarty, MD, Eli Lilly and Company; C.L. Shuler, MS, Eli Lilly and Company; H. Carlier, PhD, Eli Lilly and Company; O. Benichou, MD, PhD, MBA, Laboratoires Lilly France; P.J. Mease, MD, Department of Rheumatology, Swedish Medical Center, and University of Washington.
Rathmann SS; From the Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands; Division of Rheumatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Immuno-Rheumatology Center, St. Luke's International Hospital, St. Luke's International University, Tokyo, Japan; Eli Lilly and Company, Indianapolis, Indiana, USA; Laboratoires Lilly France, Neuilly, France; Department of Rheumatology, Swedish Medical Center; University of Washington, Seattle, Washington, USA.; D. van der Heijde has received consulting fees from AbbVie and Eli Lilly and Company. D.D. Gladman has received grants or consulting fees from AbbVie and Eli Lilly and Company. M. Kishimoto received honoraria and advisory fees from AbbVie and Eli Lilly and Company. S. Rathmann, S. Moriarty, C. Shuler, and H. Carlier are employees and stockholders of Eli Lilly and Company. O. Benichou is an employee and stockholder of Laboratoires Lilly France. P.J. Mease has received research grants and has been a consultant and/or speaker for AbbVie and Eli Lilly and Company.; D. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; D.D. Gladman, MD, FRCPC, Division of Rheumatology, Department of Medicine, University of Toronto; M. Kishimoto, MD, PhD, Immuno-Rheumatology Center, St. Luke's International Hospital, St. Luke's International University; M. Okada, MD, Immuno-Rheumatology Center, St. Luke's International Hospital, St. Luke's International University; S.S. Rathmann, PhD, Eli Lilly and Company; S.R. Moriarty, MD, Eli Lilly and Company; C.L. Shuler, MS, Eli Lilly and Company; H. Carlier, PhD, Eli Lilly and Company; O. Benichou, MD, PhD, MBA, Laboratoires Lilly France; P.J. Mease, MD, Department of Rheumatology, Swedish Medical Center, and University of Washington.
Moriarty SR; From the Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands; Division of Rheumatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Immuno-Rheumatology Center, St. Luke's International Hospital, St. Luke's International University, Tokyo, Japan; Eli Lilly and Company, Indianapolis, Indiana, USA; Laboratoires Lilly France, Neuilly, France; Department of Rheumatology, Swedish Medical Center; University of Washington, Seattle, Washington, USA.; D. van der Heijde has received consulting fees from AbbVie and Eli Lilly and Company. D.D. Gladman has received grants or consulting fees from AbbVie and Eli Lilly and Company. M. Kishimoto received honoraria and advisory fees from AbbVie and Eli Lilly and Company. S. Rathmann, S. Moriarty, C. Shuler, and H. Carlier are employees and stockholders of Eli Lilly and Company. O. Benichou is an employee and stockholder of Laboratoires Lilly France. P.J. Mease has received research grants and has been a consultant and/or speaker for AbbVie and Eli Lilly and Company.; D. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; D.D. Gladman, MD, FRCPC, Division of Rheumatology, Department of Medicine, University of Toronto; M. Kishimoto, MD, PhD, Immuno-Rheumatology Center, St. Luke's International Hospital, St. Luke's International University; M. Okada, MD, Immuno-Rheumatology Center, St. Luke's International Hospital, St. Luke's International University; S.S. Rathmann, PhD, Eli Lilly and Company; S.R. Moriarty, MD, Eli Lilly and Company; C.L. Shuler, MS, Eli Lilly and Company; H. Carlier, PhD, Eli Lilly and Company; O. Benichou, MD, PhD, MBA, Laboratoires Lilly France; P.J. Mease, MD, Department of Rheumatology, Swedish Medical Center, and University of Washington.
Shuler CL; From the Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands; Division of Rheumatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Immuno-Rheumatology Center, St. Luke's International Hospital, St. Luke's International University, Tokyo, Japan; Eli Lilly and Company, Indianapolis, Indiana, USA; Laboratoires Lilly France, Neuilly, France; Department of Rheumatology, Swedish Medical Center; University of Washington, Seattle, Washington, USA.; D. van der Heijde has received consulting fees from AbbVie and Eli Lilly and Company. D.D. Gladman has received grants or consulting fees from AbbVie and Eli Lilly and Company. M. Kishimoto received honoraria and advisory fees from AbbVie and Eli Lilly and Company. S. Rathmann, S. Moriarty, C. Shuler, and H. Carlier are employees and stockholders of Eli Lilly and Company. O. Benichou is an employee and stockholder of Laboratoires Lilly France. P.J. Mease has received research grants and has been a consultant and/or speaker for AbbVie and Eli Lilly and Company.; D. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; D.D. Gladman, MD, FRCPC, Division of Rheumatology, Department of Medicine, University of Toronto; M. Kishimoto, MD, PhD, Immuno-Rheumatology Center, St. Luke's International Hospital, St. Luke's International University; M. Okada, MD, Immuno-Rheumatology Center, St. Luke's International Hospital, St. Luke's International University; S.S. Rathmann, PhD, Eli Lilly and Company; S.R. Moriarty, MD, Eli Lilly and Company; C.L. Shuler, MS, Eli Lilly and Company; H. Carlier, PhD, Eli Lilly and Company; O. Benichou, MD, PhD, MBA, Laboratoires Lilly France; P.J. Mease, MD, Department of Rheumatology, Swedish Medical Center, and University of Washington.
Carlier H; From the Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands; Division of Rheumatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Immuno-Rheumatology Center, St. Luke's International Hospital, St. Luke's International University, Tokyo, Japan; Eli Lilly and Company, Indianapolis, Indiana, USA; Laboratoires Lilly France, Neuilly, France; Department of Rheumatology, Swedish Medical Center; University of Washington, Seattle, Washington, USA.; D. van der Heijde has received consulting fees from AbbVie and Eli Lilly and Company. D.D. Gladman has received grants or consulting fees from AbbVie and Eli Lilly and Company. M. Kishimoto received honoraria and advisory fees from AbbVie and Eli Lilly and Company. S. Rathmann, S. Moriarty, C. Shuler, and H. Carlier are employees and stockholders of Eli Lilly and Company. O. Benichou is an employee and stockholder of Laboratoires Lilly France. P.J. Mease has received research grants and has been a consultant and/or speaker for AbbVie and Eli Lilly and Company.; D. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; D.D. Gladman, MD, FRCPC, Division of Rheumatology, Department of Medicine, University of Toronto; M. Kishimoto, MD, PhD, Immuno-Rheumatology Center, St. Luke's International Hospital, St. Luke's International University; M. Okada, MD, Immuno-Rheumatology Center, St. Luke's International Hospital, St. Luke's International University; S.S. Rathmann, PhD, Eli Lilly and Company; S.R. Moriarty, MD, Eli Lilly and Company; C.L. Shuler, MS, Eli Lilly and Company; H. Carlier, PhD, Eli Lilly and Company; O. Benichou, MD, PhD, MBA, Laboratoires Lilly France; P.J. Mease, MD, Department of Rheumatology, Swedish Medical Center, and University of Washington.
Benichou O; From the Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands; Division of Rheumatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Immuno-Rheumatology Center, St. Luke's International Hospital, St. Luke's International University, Tokyo, Japan; Eli Lilly and Company, Indianapolis, Indiana, USA; Laboratoires Lilly France, Neuilly, France; Department of Rheumatology, Swedish Medical Center; University of Washington, Seattle, Washington, USA.; D. van der Heijde has received consulting fees from AbbVie and Eli Lilly and Company. D.D. Gladman has received grants or consulting fees from AbbVie and Eli Lilly and Company. M. Kishimoto received honoraria and advisory fees from AbbVie and Eli Lilly and Company. S. Rathmann, S. Moriarty, C. Shuler, and H. Carlier are employees and stockholders of Eli Lilly and Company. O. Benichou is an employee and stockholder of Laboratoires Lilly France. P.J. Mease has received research grants and has been a consultant and/or speaker for AbbVie and Eli Lilly and Company.; D. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; D.D. Gladman, MD, FRCPC, Division of Rheumatology, Department of Medicine, University of Toronto; M. Kishimoto, MD, PhD, Immuno-Rheumatology Center, St. Luke's International Hospital, St. Luke's International University; M. Okada, MD, Immuno-Rheumatology Center, St. Luke's International Hospital, St. Luke's International University; S.S. Rathmann, PhD, Eli Lilly and Company; S.R. Moriarty, MD, Eli Lilly and Company; C.L. Shuler, MS, Eli Lilly and Company; H. Carlier, PhD, Eli Lilly and Company; O. Benichou, MD, PhD, MBA, Laboratoires Lilly France; P.J. Mease, MD, Department of Rheumatology, Swedish Medical Center, and University of Washington.
Mease PJ; From the Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands; Division of Rheumatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Immuno-Rheumatology Center, St. Luke's International Hospital, St. Luke's International University, Tokyo, Japan; Eli Lilly and Company, Indianapolis, Indiana, USA; Laboratoires Lilly France, Neuilly, France; Department of Rheumatology, Swedish Medical Center; University of Washington, Seattle, Washington, USA.; D. van der Heijde has received consulting fees from AbbVie and Eli Lilly and Company. D.D. Gladman has received grants or consulting fees from AbbVie and Eli Lilly and Company. M. Kishimoto received honoraria and advisory fees from AbbVie and Eli Lilly and Company. S. Rathmann, S. Moriarty, C. Shuler, and H. Carlier are employees and stockholders of Eli Lilly and Company. O. Benichou is an employee and stockholder of Laboratoires Lilly France. P.J. Mease has received research grants and has been a consultant and/or speaker for AbbVie and Eli Lilly and Company.; D. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; D.D. Gladman, MD, FRCPC, Division of Rheumatology, Department of Medicine, University of Toronto; M. Kishimoto, MD, PhD, Immuno-Rheumatology Center, St. Luke's International Hospital, St. Luke's International University; M. Okada, MD, Immuno-Rheumatology Center, St. Luke's International Hospital, St. Luke's International University; S.S. Rathmann, PhD, Eli Lilly and Company; S.R. Moriarty, MD, Eli Lilly and Company; C.L. Shuler, MS, Eli Lilly and Company; H. Carlier, PhD, Eli Lilly and Company; O. Benichou, MD, PhD, MBA, Laboratoires Lilly France; P.J. Mease, MD, Department of Rheumatology, Swedish Medical Center, and University of Washington.
Pokaż więcej
Źródło :
The Journal of rheumatology [J Rheumatol] 2018 Mar; Vol. 45 (3), pp. 367-377. Date of Electronic Publication: 2017 Dec 15.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibodies, Monoclonal, Humanized/*adverse effects
Antibodies, Monoclonal, Humanized/*therapeutic use
Arthritis, Psoriatic/*drug therapy
Dermatologic Agents/*adverse effects
Dermatologic Agents/*therapeutic use
Adalimumab/administration & dosage ; Adalimumab/therapeutic use ; Adult ; Antibodies, Monoclonal, Humanized/administration & dosage ; Antibodies, Monoclonal, Humanized/pharmacology ; Antirheumatic Agents/administration & dosage ; Antirheumatic Agents/therapeutic use ; Back Pain/chemically induced ; Dermatologic Agents/administration & dosage ; Dermatologic Agents/pharmacology ; Double-Blind Method ; Female ; Humans ; Injection Site Reaction/etiology ; Interleukin-17/antagonists & inhibitors ; Male ; Middle Aged ; Nasopharyngitis/chemically induced ; Quality of Life ; Respiratory Tract Infections/etiology ; Severity of Illness Index ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Comparison of NIRS, serum biomarkers, and muscle damage in a porcine balloon compression model of acute compartment syndrome.
Autorzy :
Budsberg SC; From the Department of Small Animal Medicine and Surgery (S.C.B,. M.S.S., M.H), College of Veterinary Medicine, University of Georgia, Athens, Georgia; Department of Upper Extremity and Micro Surgery (M.S.S.), Athens Orthopedic Clinic, PA, Athens, Georgia; Department of Pathology, College of Veterinary Medicine (E.U.), University of Georgia, Athens, Georgia; Landstuhl Regional Medical Center (B.A.F.), Landstuhl, Germany.
Shuler MS
Hansen M
Uhl E
Freedman BA
Pokaż więcej
Źródło :
The journal of trauma and acute care surgery [J Trauma Acute Care Surg] 2016 Nov; Vol. 81 (5), pp. 876-881.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Spectroscopy, Near-Infrared*
Biomarkers/*blood
Compartment Syndromes/*diagnosis
Muscle, Skeletal/*physiopathology
Acute Disease ; Animals ; Body Fluid Compartments/physiology ; Compartment Syndromes/blood ; Compartment Syndromes/physiopathology ; Disease Models, Animal ; Pressure ; Sensitivity and Specificity ; Swine ; Tibia
Czasopismo naukowe
Tytuł :
Use of Near-Infrared Spectroscopy to Detect Sustained Hyperaemia Following Lower Extremity Trauma.
Autorzy :
Reisman WM; Department of Orthopedics, Grady Memorial Hospital, 80 Jesse Hill Jr. Drive SE, Atlanta, GA 30303.
Shuler MS; Athens Orthopedic Clinic, 1765 Old West Broad Street, Building 2, Suite 200, Athens, GA 30606.
Roskosky M; Athens Orthopedic Clinic, 1765 Old West Broad Street, Building 2, Suite 200, Athens, GA 30606.
Kinsey TL; Athens Orthopedic Clinic, 1765 Old West Broad Street, Building 2, Suite 200, Athens, GA 30606.
Freedman BA; Landstuhl Regional Medical Center, Geb 3765, 66849, Landstuhl, Germany.
Pokaż więcej
Źródło :
Military medicine [Mil Med] 2016 Feb; Vol. 181 (2), pp. 111-5.
Typ publikacji :
Evaluation Study; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Spectroscopy, Near-Infrared*
Compartment Syndromes/*diagnostic imaging
Hyperemia/*diagnostic imaging
Leg/*blood supply
Leg Injuries/*diagnosis
Adult ; Compartment Syndromes/etiology ; Female ; Humans ; Hyperemia/etiology ; Leg Injuries/complications ; Leg Injuries/surgery ; Male ; Middle Aged ; Probability ; Young Adult
Czasopismo naukowe
Tytuł :
Cadaveric Study of Appropriate Screw Length for Distal Radius Stabilization Using Volar Plate Fixation.
Autorzy :
Austin A
Green S
Ahsan S
Roskosky M
Shuler MS; Athens Orthopedic Clinic, Athens, GA. .
Pokaż więcej
Źródło :
American journal of orthopedics (Belle Mead, N.J.) [Am J Orthop (Belle Mead NJ)] 2015 Aug; Vol. 44 (8), pp. 369-72.
Typ publikacji :
Journal Article
MeSH Terms :
Bone Plates*
Bone Screws*
Fracture Fixation, Internal/*instrumentation
Radius Fractures/*surgery
Tendon Injuries/*surgery
Wrist Joint/*surgery
Cadaver ; Female ; Fluoroscopy ; Humans ; Male ; Radius Fractures/diagnostic imaging ; Tomography, X-Ray Computed ; Wrist Joint/diagnostic imaging
Czasopismo naukowe
Tytuł :
The Regional Asthma Disease Management Program (RADMP) for low income underserved children in rural western North Carolina: a National Asthma Control Initiative Demonstration Project.
Autorzy :
Shuler MS; a Regional Asthma Disease Management Program, Mission Children's Hospital , Asheville , NC , USA .
Yeatts KB; b Department of Epidemiology , UNC-Chapel Hill , Chapel Hill , NC , USA , and.
Russell DW; a Regional Asthma Disease Management Program, Mission Children's Hospital , Asheville , NC , USA .
Trees AS; a Regional Asthma Disease Management Program, Mission Children's Hospital , Asheville , NC , USA .
Sutherland SE; c Mission Hospital, Research Institute , Asheville , NC , USA.
Pokaż więcej
Źródło :
The Journal of asthma : official journal of the Association for the Care of Asthma [J Asthma] 2015; Vol. 52 (9), pp. 881-8. Date of Electronic Publication: 2015 Aug 18.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Disease Management*
Poverty*
Rural Population*
Asthma/*therapy
Community Health Services/*organization & administration
Patient Education as Topic/*organization & administration
Absenteeism ; Child ; Child, Preschool ; Continental Population Groups ; Emergency Service, Hospital/statistics & numerical data ; Environment ; Female ; Health Expenditures/statistics & numerical data ; Humans ; Male ; North Carolina ; Respiratory Function Tests ; Severity of Illness Index
Czasopismo naukowe
Tytuł :
Subcutaneous depth in a traumatized lower extremity.
Autorzy :
Roskosky M; From the Athens Orthopedic Clinic (M.R., M.S.S.), Athens, Georgia; The Geneva Foundation (M.R., G.R.), Tacoma, Washington; Emory School of Medicine (W.R.), Atlanta, Georgia; Atlanta Medical Center (B.Z.), Atlanta, Georgia; and Landstuhl Regional Medical Center (B.F.), Landstuhl, Germany.
Robinson G
Reisman W
Ziran B
Shuler MS
Freedman B
Pokaż więcej
Źródło :
The journal of trauma and acute care surgery [J Trauma Acute Care Surg] 2014 Sep; Vol. 77 (3 Suppl 2), pp. S190-3.
Typ publikacji :
Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Leg Injuries/*diagnosis
Adolescent ; Adult ; Aged ; Body Mass Index ; Compartment Syndromes/diagnosis ; Compartment Syndromes/etiology ; Female ; Humans ; Leg Injuries/complications ; Leg Injuries/pathology ; Male ; Middle Aged ; Spectroscopy, Near-Infrared ; Subcutaneous Fat/pathology ; Young Adult
Czasopismo naukowe
Tytuł :
Correlation of near-infrared spectroscopy and direct pressure monitoring in an acute porcine compartmental syndrome model.
Autorzy :
Cathcart CC; Department of Small Animal Medicine and Surgery, College of Veterinary Medicine, University of Georgia, Athens, GA; †Department of Upper Extremity and Micro Surgery, Athens Orthopedic Clinic, Athens GA; and ‡Landstuhl Regional Medical Center, Landstuhl, Germany.
Shuler MS
Freedman BA
Reno LR
Budsberg SC
Pokaż więcej
Źródło :
Journal of orthopaedic trauma [J Orthop Trauma] 2014 Jun; Vol. 28 (6), pp. 365-9.
Typ publikacji :
Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Compartment Syndromes/*physiopathology
Lower Extremity/*physiopathology
Animals ; Disease Models, Animal ; Female ; Lower Extremity/blood supply ; Male ; Muscle, Skeletal/blood supply ; Muscle, Skeletal/chemistry ; Muscle, Skeletal/physiopathology ; Oxygen/analysis ; Pressure ; Spectroscopy, Near-Infrared ; Swine
Czasopismo naukowe
Tytuł :
Relationship between near infrared spectroscopy and intra-compartmental pressures.
Autorzy :
Reisman WM; Emory University, Atlanta, GA 30606, USA.
Shuler MS
Kinsey TL
Cole AL
Whitesides TE Jr
Davila MG
Smith EK
Moore TJ
Pokaż więcej
Źródło :
The Journal of emergency medicine [J Emerg Med] 2013 Feb; Vol. 44 (2), pp. 292-8. Date of Electronic Publication: 2012 Aug 24.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Spectroscopy, Near-Infrared*
Compartment Syndromes/*physiopathology
Muscle, Skeletal/*blood supply
Regional Blood Flow/*physiology
Acute Disease ; Adult ; Female ; Humans ; Lower Extremity/blood supply ; Male ; Models, Biological ; Prospective Studies ; Tourniquets
Czasopismo naukowe
Tytuł :
What's new in acute compartment syndrome?
Autorzy :
Harvey EJ; Department of Surgery, Division of Orthopaedic Surgery, McGill University, Montreal, Quebec, Canada. />Sanders DW
Shuler MS
Lawendy AR
Cole AL
Alqahtani SM
Schmidt AH
Pokaż więcej
Źródło :
Journal of orthopaedic trauma [J Orthop Trauma] 2012 Dec; Vol. 26 (12), pp. 699-702.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Anti-Inflammatory Agents/*therapeutic use
Compartment Syndromes/*diagnosis
Compartment Syndromes/*therapy
Manometry/*trends
Wounds and Injuries/*diagnosis
Wounds and Injuries/*therapy
Acute Disease ; Compartment Syndromes/etiology ; Humans ; Wounds and Injuries/complications
Czasopismo naukowe
Tytuł :
Ability of near infrared spectroscopy to measure oxygenation in isolated upper extremity muscle compartments.
Autorzy :
Cole AL; Department of Upper Extremity and Micro Surgery, Athens Orthopedic Clinic, PA, USA.
Herman RA Jr
Heimlich JB
Ahsan S
Freedman BA
Shuler MS
Pokaż więcej
Źródło :
The Journal of hand surgery [J Hand Surg Am] 2012 Feb; Vol. 37 (2), pp. 297-302. Date of Electronic Publication: 2011 Dec 20.
Typ publikacji :
Controlled Clinical Trial; Journal Article
MeSH Terms :
Spectroscopy, Near-Infrared*
Muscle Contraction/*physiology
Muscle, Skeletal/*physiology
Oxygen Consumption/*physiology
Adolescent ; Adult ; Aged ; Exercise/physiology ; Female ; Forearm ; Humans ; Male ; Middle Aged ; Oximetry ; Sensitivity and Specificity ; Young Adult
Czasopismo naukowe
Tytuł :
Correlation between muscle oxygenation and compartment pressures in acute compartment syndrome of the leg.
Autorzy :
Shuler MS; Grady Memorial Hospital, Atlanta, Georgia, USA. />Reisman WM
Kinsey TL
Whitesides TE Jr
Hammerberg EM
Davila MG
Moore TJ
Pokaż więcej
Źródło :
The Journal of bone and joint surgery. American volume [J Bone Joint Surg Am] 2010 Apr; Vol. 92 (4), pp. 863-70.
Typ publikacji :
Journal Article
MeSH Terms :
Compartment Syndromes/*physiopathology
Leg Injuries/*complications
Muscle, Skeletal/*blood supply
Oxygen/*blood
Acute Disease ; Adolescent ; Adult ; Compartment Syndromes/etiology ; Humans ; Male ; Middle Aged ; Pressure ; Spectroscopy, Near-Infrared ; Young Adult
Czasopismo naukowe
Tytuł :
Near-infrared spectroscopy in lower extremity trauma.
Autorzy :
Shuler MS; Grady Memorial Hospital and Emory University, Atlanta, Georgia, USA. />Reisman WM
Whitesides TE Jr
Kinsey TL
Hammerberg EM
Davila MG
Moore TJ
Pokaż więcej
Źródło :
The Journal of bone and joint surgery. American volume [J Bone Joint Surg Am] 2009 Jun; Vol. 91 (6), pp. 1360-8.
Typ publikacji :
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Spectroscopy, Near-Infrared*
Compartment Syndromes/*diagnosis
Leg/*blood supply
Leg Injuries/*diagnosis
Adolescent ; Adult ; Case-Control Studies ; Female ; Humans ; Injury Severity Score ; Leg Injuries/surgery ; Magnetic Resonance Imaging ; Male ; Microcirculation/physiology ; Middle Aged ; Oxygen Consumption/physiology ; Probability ; Reference Values ; Regional Blood Flow ; Sensitivity and Specificity ; Young Adult
Czasopismo naukowe
Tytuł :
Basal joint arthritis of the thumb.
Autorzy :
Shuler MS; Department of Orthopaedics and Sports Medicine, University of Washington, 1959 NE Pacific Street, Seattle, WA 98195, USA.
Luria S
Trumble TE
Pokaż więcej
Źródło :
The Journal of the American Academy of Orthopaedic Surgeons [J Am Acad Orthop Surg] 2008 Jul; Vol. 16 (7), pp. 418-23.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Thumb*
Arthritis/*physiopathology
Carpometacarpal Joints/*physiopathology
Arthritis/classification ; Arthritis/surgery ; Biomechanical Phenomena ; Carpometacarpal Joints/surgery ; Humans ; Orthopedic Procedures/methods ; Treatment Outcome
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies